Wolf Herman Fridman
Overview
Explore the profile of Wolf Herman Fridman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
10924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Calderaro J, Petitprez F, Becht E, Laurent A, Hirsch T, Rousseau B, et al.
J Hepatol
. 2018 Sep;
70(1):58-65.
PMID: 30213589
Background & Aims: Tertiary lymphoid structures (TLSs) provide a local and critical microenvironment for generating anti-tumor cellular and humoral immune responses. TLSs are associated with improved clinical outcomes in most...
22.
Yagi H, Takakura D, Roumenina L, Fridman W, Sautes-Fridman C, Kawasaki N, et al.
Sci Rep
. 2018 Feb;
8(1):2719.
PMID: 29426894
Fc-receptors for immunoglobulin G (FcγRs) mediate a variety of effector and regulatory mechanisms in the immune system. N-glycosylation of FcγRs critically affects their functions which is well exemplified by antibody-dependent...
23.
Daugan M, Noe R, Fridman W, Sautes-Fridman C, Roumenina L
Med Sci (Paris)
. 2017 Oct;
33(10):871-877.
PMID: 28994383
The complement system is a key component of the innate immunity, playing a role in pathogen elimination and in host homeostasis. The complement system has been considered for long time...
24.
Petitprez F, Fossati N, Vano Y, Freschi M, Becht E, Luciano R, et al.
Eur Urol Focus
. 2017 Jul;
5(2):192-196.
PMID: 28753812
Prostate cancer (PCa) patients with lymph node invasion at radical prostatectomy are at higher risk of tumor recurrence and receive immediate androgen deprivation therapy (ADT). While approximately 30% of these...
25.
Sautes-Fridman C, Lawand M, Giraldo N, Kaplon H, Germain C, Fridman W, et al.
Front Immunol
. 2016 Oct;
7:407.
PMID: 27752258
Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates that reflect lymphoid neogenesis occurring in tissues at sites of inflammation. They are detected in tumors where they orchestrate local and systemic...
26.
Dieu-Nosjean M, Giraldo N, Kaplon H, Germain C, Fridman W, Sautes-Fridman C
Immunol Rev
. 2016 Apr;
271(1):260-75.
PMID: 27088920
The characterization of the microenvironment of human tumors led to the description of tertiary lymphoid structures (TLS) characterized by mature dendritic cells in a T-cell zone adjacent to B-cell follicle...
27.
Becht E, De Reynies A, Giraldo N, Pilati C, Buttard B, Lacroix L, et al.
Clin Cancer Res
. 2016 Mar;
22(16):4057-66.
PMID: 26994146
Purpose: The tumor microenvironment is formed by many distinct and interacting cell populations, and its composition may predict patients' prognosis and response to therapies. Colorectal cancer is a heterogeneous disease...
28.
Becht E, Giraldo N, Dieu-Nosjean M, Sautes-Fridman C, Fridman W
Curr Opin Immunol
. 2015 Dec;
39:7-13.
PMID: 26708937
The immune contexture that characterizes the density, the location, the organization and the functional orientation of tumor-infiltrating immune cells in cancers has a clinical impact on patient's outcome. It is,...
29.
Sautes-Fridman C, Fridman W
Trends Immunol
. 2015 Dec;
37(1):1-2.
PMID: 26706045
The role of tertiary lymphoid structures (TLS) in cancer has recently been illustrated and revisited using mouse models. Joshi et al. describe regulatory T (Treg) cell infiltration and functional heterogeneity...
30.
Becht E, Giraldo N, Beuselinck B, Job S, Marisa L, Vano Y, et al.
Oncoimmunology
. 2015 Nov;
4(12):e1049804.
PMID: 26587318
Molecular and immune classifications powerfully predict cancer patient's survival and response to therapies. We herein describe the immune tumor microenvironment of molecular subgroups of colorectal and renal cell cancers, revealing...